Collaboration Revenue - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation Of Revenue [Line Items]
Collaboration revenue		$ 351,367	$ 48,633
Research and development expense	$ 81,936	167,205	38,023
Accrued expenses and other current liabilities	15,206	52,152
Prepaid expenses and other current assets	14,213	8,028
Roche License Agreement
Disaggregation Of Revenue [Line Items]
Collaboration revenue		351,367	48,633
Costs reimbursed amount		7,264	7,901
Research and development expense		76,567	$ 2,086
Accrued expenses and other current liabilities		$ 10,417
Research and development net credit adjustment	6,898
Prepaid expenses and other current assets	$ 1,060